Barton recently announced a $3 million equity accretive placement priced at a ~4% premium to its last traded price, and a ~25% premium to its 20 trading day volume weighted average price (VWAP). [2] ...
Reprinted with permission from the Association of Clinical Documentation Improvement Specialists (ACDIS) CDI Journal.While many clinical documentation improvement programs try to measure the impact of ...
Baseline Therapeutics, Inc. ("Baseline"), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to advance a new generation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results